It has been described that activation of the FXR-dependent pathway promotes metabolic disease in diet-induced and genetically obese rodents in a mechanism involving microbial imbalance (Gonzalez et al., 2016), due to the capacity of intestinal microbiota to alter the BA pool and signaling properties (Arab et al., 2017). Here, NR1H4 is linked to Other metabolic disease.